MENU
+Compare
CDXC
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$5.94
Change
+$0.29 (+5.13%)
Capitalization
453.72M

CDXC ChromaDex Corp Forecast, Technical & Fundamental Analysis

a developer of proprietary-based ingredient technologies

Industry Biotechnology
CDXC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CDXC with price predictions
Jan 08, 2025

CDXC's RSI Oscillator recovers from oversold territory

The RSI Oscillator for CDXC moved out of oversold territory on January 02, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In of the 32 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where CDXC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 08, 2025. You may want to consider a long position or call options on CDXC as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CDXC advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day moving average for CDXC crossed bearishly below the 50-day moving average on December 24, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDXC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CDXC entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CDXC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDXC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.210) is normal, around the industry mean (14.746). P/E Ratio (297.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). CDXC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (4.950) is also within normal values, averaging (264.084).

View a ticker or compare two or three
CDXC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CDXC is expected to report earnings to rise 25.00% to 2 cents per share on March 05

ChromaDex Corp CDXC Stock Earnings Reports
Q4'24
Est.
$0.03
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.01
Q4'23
Beat
by $0.02
The last earnings report on October 31 showed earnings per share of 1 cents, beating the estimate of 0 cents. With 364.99K shares outstanding, the current market capitalization sits at 453.72M.
A.I. Advisor
published General Information

General Information

a developer of proprietary-based ingredient technologies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
10900 Wilshire Boulevard
Phone
+1 310 388-6706
Employees
106
Web
https://www.chromadex.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEQKX10.800.08
+0.75%
Nuveen Emerging Markets Eq Idx A
TVLCX12.110.07
+0.58%
Touchstone Value C
BMISX6.980.03
+0.43%
BNY Mellon Income Stock C
CLSPX28.780.11
+0.38%
Columbia Select Mid Cap Gro Fd I
RYHCX29.34-0.10
-0.34%
Rydex Health Care C

CDXC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXC has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CDXC jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXC
1D Price
Change %
CDXC100%
+5.13%
AXON - CDXC
43%
Loosely correlated
+1.37%
EDIT - CDXC
36%
Loosely correlated
-1.61%
ORMP - CDXC
35%
Loosely correlated
-1.72%
AMRN - CDXC
35%
Loosely correlated
+0.72%
CYTK - CDXC
35%
Loosely correlated
-2.66%
More